Kansas State University
#mitochondria #bioenergetics #neuropsychiatry To view or add a comment, sign in Could GLP-1based therapies have a future role in migraine management
What is well-established: Kisspeptin is essential for normal reproductive hormone signaling Kisspeptin-10 and kisspeptin-54 can trigger LH release in clinical settings Kisspeptin-based ovulation triggering in IVF shows genuine clinical promise Kisspeptin dysregulation is measurably involved in PMOS and FHA pathophysiology What is still under investigation: Optimal dosing, timing, and delivery protocols outside IVF contexts Long-term safety data for ongoing or cyclical therapeutic use Clinical protocols for kisspeptin in anovulation management outside of assisted reproduction Whether exogenous kisspeptin-10 (the shorter fragment) produces equivalent clinical effects to kisspeptin-54 in fertility contexts As with many emerging peptide therapies, kisspeptin should be approached with informed expectations
Key considerations include: Always check the strength on the product label
This blockage of the blood and lymph vessels causes the physical manifestations of inflammation, namely redness, pain, stiffness, lack of mobility, and swelling
Most clinical data shows that weight loss itself often improves mood and mental health outcomes by reducing obesity-related physical limitations and social barriers
